IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ODICINO, Franco Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.568
EU - Europa 3.957
AS - Asia 1.153
OC - Oceania 32
AF - Africa 26
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.513
IT - Italia 1.708
CN - Cina 704
UA - Ucraina 625
PL - Polonia 463
DE - Germania 303
HK - Hong Kong 239
GB - Regno Unito 179
FI - Finlandia 175
CH - Svizzera 138
IE - Irlanda 135
IN - India 84
FR - Francia 76
CA - Canada 39
TR - Turchia 34
AU - Australia 29
SE - Svezia 28
ES - Italia 25
NL - Olanda 20
VN - Vietnam 20
LI - Liechtenstein 13
AR - Argentina 11
JP - Giappone 10
MX - Messico 10
BE - Belgio 9
SG - Singapore 9
PH - Filippine 8
BD - Bangladesh 7
MK - Macedonia 7
PT - Portogallo 7
RU - Federazione Russa 7
ID - Indonesia 6
IR - Iran 6
LU - Lussemburgo 6
AT - Austria 5
BR - Brasile 5
DK - Danimarca 5
EU - Europa 5
SK - Slovacchia (Repubblica Slovacca) 5
MU - Mauritius 4
PE - Perù 4
UG - Uganda 4
BS - Bahamas 3
GH - Ghana 3
JO - Giordania 3
KR - Corea 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MA - Marocco 2
MG - Madagascar 2
MY - Malesia 2
TH - Thailandia 2
BO - Bolivia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MS - Montserrat 1
NG - Nigeria 1
NO - Norvegia 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 11.767
Salva come PNG Salva come JPEG
Città #
Fairfield 926
Woodbridge 774
Ashburn 576
Houston 468
Warsaw 453
Jacksonville 442
Wilmington 387
Seattle 386
Chandler 350
Ann Arbor 338
Cambridge 324
Princeton 241
Hong Kong 234
New York 178
Dearborn 162
Nanjing 153
Dublin 135
Milan 122
Brescia 109
Helsinki 98
Beijing 97
Zurich 83
London 73
Rome 55
Des Moines 54
Boardman 52
Nanchang 50
Shenyang 49
Chicago 45
Hebei 40
Los Angeles 40
San Diego 40
Shanghai 40
Changsha 37
Jinan 31
Jiaxing 29
Toronto 28
Kunming 24
Tianjin 23
Dong Ket 20
Hangzhou 20
San Francisco 19
Washington 18
Pune 17
Pleasanton 16
Orange 15
Melbourne 14
Turin 14
Frankfurt am Main 13
Cedar Knolls 12
Haikou 12
Paris 12
Verona 12
Dalmine 11
Lancaster 11
Giubiasco 10
Hefei 10
Lanzhou 10
Zhengzhou 10
Brussels 9
Guangzhou 9
Taizhou 9
Genoa 8
Jonesboro 8
Kocaeli 8
Madrid 8
Boisar 7
Buffalo 7
Kilburn 7
Leganés 7
Ningbo 7
Sydney 7
Bergamo 6
Dubendorf 6
Norwalk 6
Osimo 6
Taiyuan 6
Bari 5
Berlin 5
Canberra 5
Florence 5
Fuzhou 5
Leawood 5
Luxembourg 5
Mariano Comense 5
Monmouth Junction 5
New Bedfont 5
Tokyo 5
Barcelona 4
Bologna 4
Buchs 4
Cazzago San Martino 4
Charlotte 4
Dallas 4
Dhaka 4
Falls Church 4
Guadalajara 4
Kanata 4
Mumbai 4
Nardò 4
Totale 8.256
Salva come PNG Salva come JPEG
Nome #
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 2.187
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 282
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 256
Claudin3 is localized outside the tight junctions in human carcinomas 225
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 218
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 147
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 146
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 141
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 140
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 132
Laparoscopic management of a large urethral leiomyoma 130
Consolidation therapies revisited: weekly paclitaxel 129
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 125
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 125
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 124
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 124
Carcinoma of the Fallopian tube 124
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 118
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas 118
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 116
Replacement therapy for breast cancer survivors. A pilot study 111
Gestational trophoblastic diseases 110
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 110
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 109
Clinical and prognostic value of 18 F-FDG PET/CT in recurrent endometrial carcinoma 109
Adnexal torsion with normal ovary in the third trimester of a twin pregnancy: Case report and literature review 108
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study 106
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 106
Carcinoma of the Fallopian tube 105
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study 105
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium 102
History of the FIGO cancer staging system 100
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers 100
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience 99
New development of the FIGO staging system. 98
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 98
Staging classification for cancer of the ovary, fallopian tube, and peritoneum 98
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 98
Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer? 97
Systemic therapy for gynecological neoplasms: ovary, cervix, and endometrium. 97
Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium 97
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimens 97
Ultrasound examination in ovarian cancer patients. A comparison with second look laparotomy 96
Early stage ovarian cancer: the Italian contribution to clinical research. An update 94
Hormone replacement therapy in breast cancer 94
Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity 93
Interval debulking surgery in advanced epithelial ovarian cancer 93
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 93
Optimizing gemcitabine regimens in ovarian cancer. 92
Revised FIGO staging for carcinoma of the cervix. 92
Five-year follow-up of placental involution after abdominal pregnancy 92
Gestational trophoblastic diseases 92
Uterine sarcomas: a clinicopathologic study 89
Crossover study with cisplatin or carboplatin in advanced ovarian cancer 89
Ovarial cancer: best timing and applications of debulking surgery 88
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 87
Staging of gynecologic malignancies 87
Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology 87
Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 86
Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship 86
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia. 86
Carcinoma of the corpus uteri 85
Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 83
Carcinoma of the corpus uteri 83
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 83
Carcinoma of the vulva 82
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy 81
Carcinoma of the vagina 78
Carcinoma of the fallopian tube. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 75
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. 75
Carcinoma of the vagina 75
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 74
Carcinoma of the cervix uteri 73
Carcinoma of the ovary 71
Cancer in women 71
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 71
Carcinoma of the ovary 70
Surgery of advanced malignant epithelial tumours of the ovary 70
Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 69
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group) 69
Carcinoma of the cervix uteri 67
The treatment of progressive ovarian carcinoma with D-Trp-LHRH (Decapeptyl). Gruppo Oncologico Nord ovest (GONO) 66
Carcinoma of the vulva. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 58
Carcinoma of the vulva 57
Gestational trophoblastic neoplasia. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 55
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study 55
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 52
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 52
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 51
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 51
Carcinoma of the vagina. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 50
Cervical cancer staging 50
HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization. 49
Uterine cervix dysplasias and viral implications 49
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 46
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 43
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 43
Management of Large Pediatric and Adolescent Ovarian Neoplasms with a Leak-Proof Extracorporeal Drainage Technique: Our Experience Using a Hybrid Minimally Invasive Approach 40
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study 37
Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks 33
Totale 11.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019538 0 0 0 0 0 0 0 0 0 0 282 256
2019/20202.568 344 80 96 279 161 347 315 287 191 273 58 137
2020/20211.580 38 162 47 181 81 178 67 190 158 266 134 78
2021/20221.033 62 156 4 44 3 51 111 72 48 127 98 257
2022/20232.153 161 60 208 275 230 286 67 149 196 128 212 181
2023/20242.166 177 106 203 156 210 377 137 184 363 245 8 0
Totale 12.181